Johnson Matthey Pharmaceutical Materials and Services provides API outsourcing solutions throughout the entire small molecule drug development process. Our facilities house self-contained manufacturing suites featuring 50-3000 gallon glass-lined and Hastelloy reactors, and more than 30 kilo-laboratories. Specialized technologies include SMB & Prep-HPLC Chromatography, Catalytic Screening, High Potency Handling, Separations, Cryogenics, and Solid Form Screening. We are able to offer a wide range of manufacturing scale from grams to hundreds of kilograms. To round out these services, our regulatory department has an impeccable track record with PAI's, FDA compliance audits, and provides CMC, IND, and NDA support to our client's regulatory filings. Behind the scenes, our scientific team works to improve and refine your process with expertise in process development, optimization, validation and scale-up, reducing time and cost. Our extensive product list includes cisplatin, carboplatin, fentanyl citrate and base, hydrocodone bitartrate, hydromorphone HCI, oxycodone HCI and oxymorphone HCl. Our sister companies Johnson Matthey Macfarlan Smith (Edinburgh, Scotland) and Alfa Aesar Research Chemicals (Ward Hill, MA) round out the Pharma division with additional manufacturing capacity, core expertise in commercial API production, and fine chemical products.